Mag2 1.5g/10ml 20 sachets oral solution

Mag2 1.5g/10ml 20 sachets oral solution is a supplement formulated to address magnesium deficiency states . Each single-dose sachet contains magnesium pidolate , equivalent to 122 mg of Mg ⁺⁺ ion , an essential element for the correct functioning of the human body. The solution is enriched with sucrose and natural flavors, offering a pleasant taste and easy intake. This product is particularly suitable for those who need an additional magnesium intake, contributing to the maintenance of normal muscle and nerve functions. The formulation in single-dose sachets guarantees convenience and precision in dosing, making it ideal for daily use.

ACTIVE INGREDIENTS

Active ingredients contained in Mag2 1.5g/10ml 20 sachets oral solution - What is the active ingredient in Mag2 1.5g/10ml 20 sachets oral solution?

One vial of oral solution contains: active ingredient: magnesium pidolate 1.500 g (corresponding to 122 mg of Mg++ ion). Excipients with known effects: sucrose, sodium methyl parahydroxybenzoate, sodium propyl parahydroxybenzoate. One single-dose sachet of oral solution contains: active ingredient: magnesium pidolate 1.500 g (corresponding to 122 mg of Mg++ ion). Excipients with known effects: sucrose, sodium methyl parahydroxybenzoate, sodium propyl parahydroxybenzoate. One sachet of powder for oral solution contains: active ingredient: magnesium pidolate 2.250 g (corresponding to 184 mg of Mg++ ion). Excipients with known effects: sucrose. For the full list of excipients, see section 6.1.

EXCIPIENTS

Composition of Mag2 1.5g/10ml 20 sachets oral solution - What does Mag2 1.5g/10ml 20 sachets oral solution contain?

MAG2 1.5 g/10 ml oral solution Sucrose, orange flavour, sodium methyl parahydroxybenzoate, sodium propyl parahydroxybenzoate, purified water. MAG2 2.25 g powder for oral solution Sodium saccharin, citric acid monohydrate, sucrose, lemon flavour.

DIRECTIONS

Therapeutic indications Mag2 1.5g/10ml 20 sachets oral solution - Why is Mag2 1.5g/10ml 20 sachets oral solution used? What is it used for?

Magnesium deficiency states.

CONTRAINDICATIONS SIDE EFFECTS

Contraindications Mag2 1.5g/10ml 20 sachets oral solution - When should Mag2 1.5g/10ml 20 sachets oral solution not be used?

Hypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. Severe renal insufficiency (creatinine clearance less than 30 mL/min). Not to be administered to subjects undergoing digitalis therapy.

DOSAGE

Quantity and method of taking Mag2 1.5g/10ml 20 sachets oral solution - How to take Mag2 1.5g/10ml 20 sachets oral solution?

Dosage For adults only: 3 vials or 3 single-dose sachets of solution or 2 sachets of powder per day. Paediatric population In children, the dosage may be established by a previously consulted doctor. Caution: use only for short periods of treatment. Instructions for use MAG2 1.5 g/10 ml oral solution: It is advisable to shake before use. To open the vial, twist the top and detach it. Take the contents of the vial as is or dilute it in water. MAG2 2.25 g powder for oral solution: Dissolve the contents of one sachet in water.

CONSERVATION

Storage Mag2 1.5g/10ml 20 sachets oral solution - How do you store Mag2 1.5g/10ml 20 sachets oral solution?

Oral solution: Store below 25°C. Powder for oral solution: This medicinal product does not require any special storage conditions.

WARNINGS

Warnings Mag2 1.5g/10ml 20 sachets oral solution - About Mag2 1.5g/10ml 20 sachets oral solution it is important to know that:

In case of concomitant calcium deficiency, magnesium deficiency should be corrected before administering supplemental calcium. In patients with moderate renal insufficiency, it is necessary to reduce the dosage and monitor renal function and magnesium levels, due to the risk associated with hypermagnesemia. It is advisable to consider the possibility that cardiovascular depression may occur during treatment. Each vial of MAG2 solution contains 3.5 g of sucrose. Each single-dose sachet of MAG2 solution contains 3.5 g of sucrose. Each sachet of MAG2 powder contains 2.985 g of sucrose. If taken in accordance with the recommended dose, the daily intake of sucrose corresponds to 10.5 g for vials and single-dose sachets of solution and 5.97 g for sachets of powder. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. MAG2 oral solution contains parahydroxybenzoates (sodium methyl parahydroxybenzoate and sodium propyl parahydroxybenzoate): may cause allergic reactions (possibly delayed). MAG2 vials, single-dose sachets of solution and powder for oral solution contain less than 1 mmol sodium (23 mg) per vial or sachet, i.e. essentially “sodium-free”.

INTERACTIONS

Interactions Mag2 1.5g/10ml 20 sachets oral solution - Which medicines or foods can modify the effect of Mag2 1.5g/10ml 20 sachets oral solution?

In case of concomitant treatment with oral tetracyclines, the administration of MAG2 should be delayed by at least 3 hours. Quinolones should be administered at least 2 hours before or 6 hours after the administration of magnesium-containing products to avoid interference with their absorption. The concomitant administration of magnesium-containing products and cholecalciferol (vitamin D3) may lead to the onset of hypercalcemia. The concomitant use of preparations containing calcium or phosphate salts is not recommended because these products prevent intestinal absorption of magnesium. The simultaneous intake of magnesium-containing products with drugs that depress the Central Nervous System may potentiate the effects of magnesium on the CNS and should be carefully evaluated.

SIDE EFFECTS

Like all medicines, Mag2 1.5g/10ml 20 sachets oral solution can cause side effects - What are the side effects of Mag2 1.5g/10ml 20 sachets oral solution?

The following convention has been used for the classification of undesirable effects: very common ≥ 1/10; common ≥ 1/100 and < 1/10; uncommon ≥ 1/1,000 and < 1/100; rare ≥ 1/10,000 and < 1/1,000); very rare < 1/10,000 and not known (frequency cannot be estimated from the available data). Gastrointestinal disorders. Frequency not known: gastrointestinal disorders, diarrhoea, abdominal pain. Skin and subcutaneous tissue disorders. Frequency not known: skin reactions. Immune system disorders. Frequency not known: hypersensitivity. Exceptional cases of individual intolerance to magnesium have been reported, which can be treated with oral or parenteral antihistamines. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/web/guest/content/segnalazioni-reazioni-avverse.

OVERDOSE

Overdose Mag2 1.5g/10ml 20 sachets oral solution - What are the risks of Mag2 1.5g/10ml 20 sachets oral solution in case of overdose?

Signs and symptoms Oral magnesium overdose does not generally induce toxic reactions in the presence of normal renal function. However, magnesium poisoning may develop in cases of severe renal insufficiency. The toxic effect depends mainly on serum magnesium levels and the signs are as follows: drop in blood pressure, nausea, vomiting, depression of the Central Nervous System, decreased reflexes, ECG abnormalities (e.g. cardiac rhythm disturbances), onset of respiratory depression, coma, cardiac arrest, respiratory paralysis, anuric syndrome and disturbances of neuromuscular transmission. Therapy Treatment should include rehydration with restoration of abundant diuresis or forced diuresis. In the presence of renal insufficiency, haemodialysis or peritoneal dialysis is necessary.

PREGNANCY AND BREASTFEEDING

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Mag2 1.5g/10ml 20 sachets oral solution

There are limited data on the use of MAG2 in pregnant women. However, no conclusions can be drawn as to whether the use of MAG2 is safe during pregnancy. MAG2 can be used during pregnancy only if the potential benefits to the mother outweigh the potential risks, including those to the fetus. Magnesium is considered compatible with breastfeeding.

DRIVING AND USE OF MACHINERY

Taking Mag2 1.5g/10ml 20 sachets oral solution before driving or using machines - Does Mag2 1.5g/10ml 20 sachets oral solution affect driving or using machines?

Mag2 1.5g/10ml 20 sachets oral solution does not alter the ability to drive vehicles or use machinery.